glp 1 adoption New Demand in an Old Market GLP-1 Drugs: Catalysts for a

ITCA-650 is a long-acting version of exenatide enabling sustained peptide delivery with implantation of a small s.c

It takes only a few minutes and helps our clinical team understand your symptoms and goals

Harasta AE, Power JM, von Jonquieres G, Karl T, Drucker DJ, Housley GD et al

10.1172/JCI43703 [DOI] [PMC free article] [PubMed] [Google Scholar] Scrocchi, L

GLP-1s are medications designed to manage type 2 diabetes, heart disease and obesity by lowering blood sugar and A1C, interacting with the hunger part of the brain to suppress the appetite and slowing down the process of food emptying from the stomach, causing patients to feel full longer